Nicholas Lydon - Insider Trading & Ownership

Location
Blueprint Medicines Corp., 215 First Street, Suite 340/350, Cambridge, MA
Summary
The estimated net worth of Nicholas Lydon is at least $6.17M dollars as of June 14, 2024. Nicholas Lydon is the Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp (BPMC) stock worth about $6.17M.
Signature
/s/ Melissa Masse
All Insider Reports
All Insider Reports

Email me when Lydon Nicholas files a new Ownership 3,4,5 report.

⭐ Subscribe ⭐

Ownership of Nicholas Lydon

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BPMC Blueprint Medicines Corp Director $6.17M Jun 12, 2024

Insider Transactions Reported by Nicholas Lydon:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.